Advances in synthetic materials and skin patch designs have led to transdermal drug delivery products that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Transdermal drug delivery patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Growth is being driven by several factors – factors with strong demographic and population trend underpinnings. New technologies are expanding the type and number of prescription and OTC therapies and treatments that can be effectively administered to patients and consumers. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Fueled by Rx-to-OTC switching, over-the-counter patches are proliferating as companies move to capture a share of this multi-billion dollar market. Non-medicated patches are creating new and significant markets for skin patches.  The report is structured to provide transdermal drug delivery sector participants with all of the information necessary to identify marketing factors and business opportunities for transdermal drug delivery products.

Publication Date: April 2007